Logo Logo
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: 2022 | 2021 | 2019 | 2018 | 2017 | 2016
Anzahl der Publikationen: 9

2022

Bartova, Lucie; Dold, Markus; Volz, Hans-Peter; Seifritz, Erich; Moeller, Hans-Juergen und Kasper, Siegfried (2022): Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited. In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 273: S. 51-63

Volz, Hans-Peter; Saliger, Julia; Kasper, Siegfried; Moeller, Hans-Juergen und Seifritz, Erich (2022): Subsyndromal generalised anxiety disorder: operationalisation and epidemiology - a systematic literature survey. In: International Journal of Psychiatry in Clinical Practice, Bd. 26, Nr. 3: S. 277-286

Seifritz, Erich; Kasper, Siegfried; Moeller, Hans-Juergen; Volz, Hans-Peter; Mueller, Walter E.; Eckert, Anne und Hatzinger, Martin (2022): Effect of anxiolytic drug silexan on sleep - a narrative review. In: World Journal of Biological Psychiatry, Bd. 23, Nr. 7: S. 493-500

2021

Moeller, Hans-Jürgen; Volz, Hans-Peter; Seifritz, Erich; Mueller, Heiko; Kenntner-Mabiala, Ramona; Kaussner, Yvonne; Schoch, Stefanie und Kasper, Siegfried (2021): Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers. In: Journal of Psychiatric Research, Bd. 136: S. 543-551

Seifritz, Erich; Moeller, Hans-Jürgen; Volz, Hans-Peter; Mueller, Walter E.; Hopyan, Talar; Wacker, Anna; Schlaefke, Sandra und Kasper, Siegfried (2021): No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial. In: International Journal of Neuropsychopharmacology, Bd. 24, Nr. 3: S. 171-180

2019

Moeller, Hans-Jürgen; Volz, Hans-Peter; Dienel, Angelika; Schlaefke, Sandra und Kasper, Siegfried (2019): Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials. In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 269, Nr. 2: S. 183-193

2018

Kasper, Siegfried; Müller, Walter E.; Volz, Hans-Peter; Möller, Hans-Jürgen; Koch, Egon und Dienel, Angelika (2018): Silexan in anxiety disorders: Clinical data and pharmacological background. In: World Journal of Biological Psychiatry, Bd. 19, Nr. 6: S. 412-420

2017

Kasper, Siegfried; Möller, Hans-Jürgen; Volz, Hans-Peter; Schläfke, Sandra und Dienel, Angelika (2017): Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set. In: International Clinical Psychopharmacology, Bd. 32, Nr. 4: S. 195-204

2016

Möller, Hans-Jürgen; Bandelow, Borwin; Volz, Hans-Peter; Barnikol, Utako Birgit; Seifritz, Erich und Kasper, Siegfried (2016): The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice. In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 266, Nr. 8: S. 725-736

Diese Liste wurde am Sat Nov 16 23:21:58 2024 CET erstellt.